Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price (AJANTPHARM)

₹17990.05%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q1 '23 Results
Technicals
News and Events

Overview of Ajanta Pharma Ltd

Key events for Ajanta Pharma Ltd

  • Ajanta Pharma Among 33 TTC Compounders - 28 Sep, 2023

    Ajanta Pharma is one of the 33 stocks that have given 100% returns in the last 20 years and can be termed through-the-cycle (TTC) compounders 100-baggers.

  • Ajanta Pharma Leads in Sales Growth - 18 Sep, 2023

    Ajanta Pharma Ltd emerged as the leader in terms of growth in August with sales growth of 11.6 percent on year.

  • Ajanta Pharma Hits Record High on Strong Business Outlook - 13 Sep, 2023

    Ajanta Pharma's stock rallies 11% to a record high on improved business outlook and strong Q1-FY24 results. The company also outperformed the market with its ophthalmology, pain therapy, and dermatology therapies.

  • Ajanta Pharma Receives USFDA Approval - 31 Aug, 2023

    Ajanta Pharma Ltd has received final approval from the United States Food and Drug Administration (USFDA) to market Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100 mg, and 200mg. The company can launch Topiramate on February 1, 2026 or earlier under certain circumstances.

  • Ajanta Pharma Receives USFDA Approval for Topiramate Extended-Release Capsules - 30 Aug, 2023

    Ajanta Pharma has received final approval from the USFDA to market Topiramate Extended-Release Capsules, a generic version of Trokendi XR™. The drug can be launched on February 1, 2026, or earlier under certain circumstances.

  • Ajanta Pharma's Debt Management Analyzed - 26 Aug, 2023

    An article analyzes Ajanta Pharma Limited's use of debt, focusing on its balance sheet and ability to manage its debt safely.

  • Ajanta Pharma Preferred by Brokerage Despite Decent US Approval - 24 Aug, 2023

    Brokerage reports that Ajanta Pharma has a decent approval in the last few months, supporting their US growth quarter-on-quarter. The brokerage continues to prefer Ajanta Pharma.

  • Ajanta Pharma Hits New 52-Week High - 17 Aug, 2023

    Ajanta Pharma Ltd's stock hits a new 52-week high at Rs 1,804.70 due to the company's focus on pharmaceutical research and development in the healthcare sector.

  • Ajanta Pharma Hits 52-Week High - 16 Aug, 2023

    Ajanta Pharma Ltd's stock hits a new milestone by reaching a 52-week high of Rs 1,804.00.

  • Ajanta Pharma Registers Growth in Indian Market - 14 Aug, 2023

    Ajanta Pharma Ltd has registered growth in the 8-11% YoY range in the Indian pharma market for July.

  • Ajanta Pharma Hits All-Time Highs - 08 Aug, 2023

    Ajanta Pharma's stock is trading at all-time highs, with shares above its IPO price. The stock also exhibits strong buying activity, but investors should watch for potential trend reversals.

  • Ajanta Pharma Announces Dividend; RSI Indicates Overbought Situation - 04 Aug, 2023

    Ajanta Pharma Ltd announces an interim dividend of Rs 10 per equity share and a special dividend of Rs 15. The company's RSI has surpassed 80, indicating a potential overbought situation.

  • Ajanta Pharma Stock Reaches 52-Week High - 03 Aug, 2023

    Ajanta Pharma Ltd's stock reached a 52-week high of Rs 1,776.70.

  • Ajanta Pharma Q1FY24 Results Show Improvement in Margins - 01 Aug, 2023

    Ajanta Pharma's Q1FY24 results show improvement in gross and EBITDA margins due to softening of raw material and freight costs. Management maintains double-digit revenue growth and margin guidance for FY24. ICICI Securities raises earnings estimates by 7%/6% and maintains BUY call with target price of INR 1,870.

  • Ajanta Pharma Posts In-Line Sales with Better-Than-Expected Profitability - 31 Jul, 2023

    Ajanta Pharma's 1QFY24 sales were in line with expectations, but profitability exceeded estimates due to lower raw material and freight costs. Earnings estimates for FY24/FY25 have been raised by 7.5% each, and the stock is rated a BUY with a TP of INR1,800.

  • Ajanta Pharma Stock Breaks Out Above Previous Swing High - 30 Jul, 2023

    Ajanta Pharma Ltd's stock has broken out above its previous swing high and is set to target even higher levels in the coming months, with a potential target of around 2200. The company is also trading ex-dividend with an upcoming dividend of ₹25.00 per share.

  • Ajanta Pharma Reports Strong Q1FY24 Results - 28 Jul, 2023

    Ajanta Pharma Ltd.'s Q1FY24 net profit surged 19.2% YoY to Rs. 208.1 crore, revenue grew 7.4% YoY to Rs. 1021 crore. The company announced a special dividend of Rs. 15 per share and regular dividend of Rs. 10 per share.

  • Ajanta Pharma Reports Strong Q1 Results and Approves Dividend - 27 Jul, 2023

    Ajanta Pharma Ltd reported strong Q1 results with revenue at Rs. 1,021 crore and approved a 1st interim dividend of Rs. 315 cr for FY 2024.

  • Ajanta Pharma Hits 52-Week High - 25 Jul, 2023

    Ajanta Pharma's stock soared to a new high, reaching Rs 1,568.00 due to its strong presence in domestic and international markets.

  • Ajanta Pharma Board to Consider Interim Dividend and Q1 Results - 24 Jul, 2023

    Ajanta Pharma's board of directors will meet on July 27 to consider declaring an interim dividend, if any, for the financial year ending March 31, 2024. The company will also announce its unaudited financial results for the June quarter in the same meeting.

Analyst Rating for Ajanta Pharma Ltd stock

based on 12 analysts

BUY
91.67%
Buy
0.00%
Hold
8.33%
Sell

Based on 12 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹1776.08

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd share Performance

  • ₹1797
    ₹1803
    ₹1799
    downward going graph

    0.11%

    Downside

    Day's Volatility:0.33%

    Upside

    0.22%

    downward going graph
  • ₹1111.6
    ₹1904.45
    ₹1799
    downward going graph

    38.21%

    Downside

    52 Weeks Volatility:44.07%

    Upside

    5.86%

    downward going graph
1 Month Return4.67 %
3 Month Return22.03 %
1 Year Return39.86 %
Previous Close₹1,799.90
Open₹1,803.00
Volume3.81L
Market Cap₹23,061.43Cr

Ajanta Pharma Ltd Company Information

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Share Price: ₹1799.00 per share as on 03 Oct, 2023 10:18 AM
Market Capitalisation: ₹23,061.43Cr as of today
Revenue: ₹918.67Cr as on March 2023 (Q1 23)
Net Profit: ₹122.25Cr as on March 2023 (Q1 23)
Listing date: 05 Jun, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Ajanta Pharma Ltd

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up
    img

    Retail Investor have increased holdings from 7.74% to 7.78% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up
    img

    Foreign Institutions have increased holdings from 10.03% to 10.19% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year
    img

    In the last 1 year, AJANTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 3 years, AJANTPHARM stock has moved up by 68.6%

  • imgNO EFFECT

    Promoter Holding Unchanged
    img

    Promoters holdings remained unchanged at 66.21% of holdings in Jun 2023 quarter

  • imgNO EFFECT

    Against Peers
    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 121.5% return, outperforming this stock by 52.9%

  • imgNEGATIVE IMPACT

    Profit Down
    img

    Netprofit is down for the last 4 quarters, 174.62 Cr → 122.25 Cr (in ₹), with an average decrease of 11.2% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down
    img

    Mutual Funds have decreased holdings from 13.72% to 13.07% in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall
    img

    Revenue is down for the last 2 quarters, 1.00K Cr → 918.67 Cr (in ₹), with an average decrease of 8.7% per quarter

Ajanta Pharma Ltd share Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (36.89x)

September 29, 2023

Industry (48.71x)

September 29, 2023

Highest (37.33x)

September 13, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
UTI Flexi Cap Fund - Growth Option - DirectUTI Flexi Cap Fund - Growth Option - Direct1.58%
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.97%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan3.02%
Kotak Small Cap Direct GrowthKotak Small Cap Direct Growth1.09%
UTI Value Opportunities Fund-Direct Growth OptionUTI Value Opportunities Fund-Direct Growth Option1.52%

Ajanta Pharma Ltd Shareholding Pattern

InvestorsHoldings %Prev. 3 periods3M change
Promoter Holdings
66.21%
0.00
Foreign Institutions
10.19%
1.62
Mutual Funds
13.07%
-4.72
Retail Investors
7.78%
0.62
Others
2.74%
18.96

Technicals of Ajanta Pharma Ltd share

News & Events of Ajanta Pharma Ltd

Frequently Asked Questions

Ajanta Pharma Ltd (AJANTPHARM) share price today is ₹1799

  • Today’s highest price of Ajanta Pharma Ltd is ₹1803.
  • Today’s lowest price of Ajanta Pharma Ltd is ₹1797.

Today’s traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 3.81L.

Today’s market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹23061.43Cr.

Ajanta Pharma Ltd(AJANTPHARMPrice
52 Week High
₹1904.45
52 Week Low
₹1111.6

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹1799. It is down -5.54% from its 52 Week High price of ₹1904.45

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹1799. It is up 61.84% from its 52 Week Low price of ₹1111.6

Ajanta Pharma Ltd(AJANTPHARMReturns
1 Day Returns
-0.9%
1 Month Returns
4.67%
3 Month Returns
22.03%
1 Year Returns
39.86%